The U.S. Food and Drug Administration (FDA) has granted clearance for U.K. AI software developer Brainomix's 360 e-Lung image processing algorithm.
Entry into the lung imaging space expands the company's footprint in medical imaging beyond its stroke-related applications. Brainomix said that it is developing novel lung imaging biomarkers, such as its weighted reticulovascular score to stratify patients at risk of idiopathic pulmonary fibrosis progression.
e-Lung consists of thousands of CT scans from academic institutions, according to the company.
Brainomix plans to present its latest e-Lung data at the American Thoracic Society (ATS) annual conference, which starts today in San Diego.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
